HAVCR2 and myelodysplastic syndrome: Asayama et al. observed genes related to proliferation elevated in TIM-3+ cells compared to TIM-3− cells in MDS blasts, and TIM-3 antibody treatment inhibited the proliferation of TIM-3+ blasts [25].